FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:8-13 July 1, 1999 Number 1 Next

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Previous studies have reported a high prevalence of mitral-valve prolapse among patients with embolic stroke (28 to 40 percent), especially among young patients (those 45 years old); this finding has practical implications for prophylaxis. However, diagnostic criteria for prolapse have changed and are now based on three-dimensional analysis of the shape of the valve; use of the current criteria reduces markedly the frequency of such a diagnosis and increases its specificity. Previously described complications must therefore be reconsidered.

Methods In a case–control study, we reviewed data on 213 consecutive patients 45 years of age or younger with documented ischemic stroke or transient ischemic attack between 1985 and 1995; they underwent complete neurologic and echocardiographic evaluations. The prevalence of prolapse in these patients was compared with that in 263 control subjects without known heart disease, who were referred to our institution for assessment of ventricular function before receiving chemotherapy.

Results Mitral-valve prolapse was present in 4 of the 213 young patients with stroke (1.9 percent), as compared with 7 of the 263 controls (2.7 percent); prolapse was present in 2 of 71 patients (2.8 percent) with otherwise unexplained stroke. The crude odds ratio for mitral-valve prolapse among the patients who had strokes, as compared with those who did not have strokes, was 0.70 (95 percent confidence interval, 0.15 to 2.80; P=0.80); after adjustment for age and sex, the odds ratio was 0.59 (95 percent confidence interval, 0.12 to 2.50; P=0.62).

Conclusions Mitral-valve prolapse is considerably less common than previously reported among young patients with stroke or transient ischemic attack, including unexplained stroke, and no more common than among controls. Using more specific and currently accepted echocardiographic criteria, therefore, we could not demonstrate an association between the presence of mitral-valve prolapse and acute ischemic neurologic events in young people.

Source Information

From the Cardiac Ultrasound Laboratory (D.G., M.L., J.E.M., R.A.L.) and the Stroke Unit, Neurology Department (F.S.B., J.P.K.), Massachusetts General Hospital and Harvard Medical School; and the Department of Biostatistics, Harvard School of Public Health (M.M.J.) — all in Boston.

Address reprint requests to Dr. Levine at the Cardiac Ultrasound Laboratory, VBK-508, Massachusetts General Hospital, 32 Fruit St., Boston, MA 02114, or at levine.robert{at}mgh.harvard.edu.

Full Text of this Article

This article has been cited by other articles:

• Salem, D. N., O'Gara, P. T., Madias, C., Pauker, S. G. (2008). Valvular and Structural Heart Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 593S-629S [Abstract] [Full Text]  
• Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., Teal, P. (2008). Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 630S-669S [Abstract] [Full Text]  
• Doufekias, E., Segal, A. Z., Kizer, J. R. (2008). Cardiogenic and aortogenic brain embolism.. J Am Coll Cardiol 51: 1049-1059 [Abstract] [Full Text]  
• McCabe, D J H, Rakhit, R D (2007). Antithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke. J. Neurol. Neurosurg. Psychiatry 78: 14-24 [Abstract] [Full Text]  
• Kizer, J. R., Devereux, R. B. (2005). Clinical practice. Patent foramen ovale in young adults with unexplained stroke.. NEJM 353: 2361-2372 [Full Text]  
• Flachskampf, F A, Daniel, W G (2005). Closure of patent foramen ovale: is the case really closed as well?. Heart 91: 449-450 [Full Text]  
• Salem, D. N., Stein, P. D., Al-Ahmad, A., Bussey, H. I., Horstkotte, D., Miller, N., Pauker, S. G. (2004). Antithrombotic Therapy in Valvular Heart Disease--Native and Prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 457S-482S [Abstract] [Full Text]  
• Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., Teal, P. (2004). Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 483S-512S [Abstract] [Full Text]  
• Tong, D. C., Becker, K. J. (2004). Patent Foramen Ovale and Recurrent Stroke: Closure Is the Best Option: No. Stroke 35: 804-805 [Full Text]  
• Avierinos, J.-F., Brown, R. D., Foley, D. A., Nkomo, V., Petty, G. W., Scott, C., Enriquez-Sarano, M. (2003). Cerebral Ischemic Events After Diagnosis of Mitral Valve Prolapse: A Community-Based Study of Incidence and Predictive Factors. Stroke 34: 1339-1344 [Abstract] [Full Text]  
• Oppenheimer, S. (2003). Editorial Comment: Is MVP an MVP in Ischemic Cerebral Events?. Stroke 34: 1345-1345 [Full Text]  
• Pellerin, D, Brecker, S, Veyrat, C (2002). Degenerative mitral valve disease with emphasis on mitral valve prolapse. Heart 88: iv20-28 [Full Text]  
• Salem, D. N., Hartnett Daudelin, D., Levine, H. J., Pauker, S. G., Eckman, M. H., Riff, J. (2001). Antithrombotic Therapy in Valvular Heart Disease. Chest 119: 207S-219S [Full Text]  
• Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., Teal, P. (2001). Antithrombotic and Thrombolytic Therapy for Ischemic Stroke. Chest 119: 300S-320S [Full Text]  
• Hassan, A., Markus, H. S. (2000). Genetics and ischaemic stroke. Brain 123: 1784-1812 [Abstract] [Full Text]  
• Kirkham, F. J., Prengler, M., Hewes, D. K.M., Ganesan, V. (2000). Risk Factors for Arterial Ischemic Stroke in Children. J Child Neurol 15: 299-307 [Abstract]  
• Stefanadis, C., Toutouzas, P. (2000). Mitral valve prolapse: The Merchant of Venice or Much Ado About Nothing ?. Eur Heart J 21: 255-258  
• (1999). Mitral-Valve Prolapse and Stroke in Young Adults. JWatch Neurology 1999: 3-3 [Full Text]  
• (1999). Has the Importance of Mitral Valve Prolapse Been Overestimated?. Journal Watch Dermatology 1999: 14-14 [Full Text]  
• (1999). Has the Importance of Mitral Valve Prolapse Been Overestimated?. JWatch Psychiatry 1999: 16-16 [Full Text]  
• (1999). Has the Importance of Mitral Valve Prolapse Been Overestimated?. JWatch General 1999: 1-1 [Full Text]  
• Nishimura, R. A., McGoon, M. D. (1999). Perspectives on Mitral-Valve Prolapse. NEJM 341: 48-50 [Full Text]